IRIS UniCatt

Bassi, Pierfrancesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.495
NA - Nord America 9.238
AS - Asia 5.973
SA - Sud America 1.234
AF - Africa 185
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 2
Totale 39.176
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.914
US - Stati Uniti d'America 8.975
SG - Singapore 2.851
DE - Germania 2.738
CN - Cina 1.561
SE - Svezia 1.501
BR - Brasile 1.003
FR - Francia 807
NL - Olanda 795
UA - Ucraina 747
GB - Regno Unito 459
IN - India 362
IE - Irlanda 354
PL - Polonia 329
VN - Vietnam 248
ID - Indonesia 237
FI - Finlandia 192
RU - Federazione Russa 190
CA - Canada 142
JP - Giappone 106
TR - Turchia 99
AR - Argentina 94
CH - Svizzera 93
BE - Belgio 92
HK - Hong Kong 91
BD - Bangladesh 82
ES - Italia 67
MX - Messico 53
IQ - Iraq 45
ZA - Sudafrica 44
CI - Costa d'Avorio 39
EC - Ecuador 36
AT - Austria 35
PK - Pakistan 34
MA - Marocco 33
KR - Corea 32
IR - Iran 27
CO - Colombia 25
RO - Romania 25
VE - Venezuela 23
AU - Australia 20
AL - Albania 19
LT - Lituania 19
AZ - Azerbaigian 18
JO - Giordania 18
UZ - Uzbekistan 18
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
PH - Filippine 16
CL - Cile 14
EG - Egitto 14
CZ - Repubblica Ceca 13
HU - Ungheria 13
BZ - Belize 12
EU - Europa 12
MY - Malesia 12
GR - Grecia 11
PA - Panama 11
PE - Perù 11
PT - Portogallo 11
TN - Tunisia 11
TW - Taiwan 11
DO - Repubblica Dominicana 10
PY - Paraguay 10
BO - Bolivia 9
IL - Israele 9
NP - Nepal 9
RS - Serbia 9
KE - Kenya 8
TH - Thailandia 8
UY - Uruguay 8
CR - Costa Rica 7
LK - Sri Lanka 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
DZ - Algeria 6
LV - Lettonia 6
NG - Nigeria 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
ET - Etiopia 5
IS - Islanda 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
SM - San Marino 5
BY - Bielorussia 4
HN - Honduras 4
HR - Croazia 4
JM - Giamaica 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
CV - Capo Verde 3
DK - Danimarca 3
EE - Estonia 3
Totale 39.115
Salva come PNG Salva come JPEG
Città #
Chandler 1.631
Milan 1.387
Singapore 1.281
Rome 1.252
Ashburn 924
Jacksonville 425
Naples 386
Dublin 342
San Mateo 333
Beijing 332
Ann Arbor 318
Los Angeles 278
Florence 258
Wilmington 247
Turin 246
Nanjing 242
Jakarta 218
Warsaw 208
Bologna 198
New York 194
Palermo 172
Bari 166
Munich 165
Houston 159
Dearborn 153
Woodbridge 146
Bremen 130
Nanchang 128
Boston 127
Nürnberg 125
Catania 124
Genoa 117
Verona 117
Frankfurt am Main 115
Lawrence 115
São Paulo 108
Fairfield 107
Hefei 104
Moscow 96
Chicago 92
Cattolica 90
Dallas 90
Marseille 89
Redwood City 87
Hong Kong 86
The Dalles 86
Seattle 85
Kraków 83
Ho Chi Minh City 82
Princeton 79
Brussels 75
Brescia 71
Hanoi 69
Padova 66
Buffalo 57
Lancaster 57
Mountain View 55
Venice 55
Cagliari 51
Falls Church 51
Ottawa 50
Tokyo 49
Parma 48
Taranto 46
Kunming 45
Helsinki 44
Izmir 43
Hyderabad 42
Redmond 42
Bergamo 41
London 41
Messina 41
Perugia 41
Reggio Emilia 41
San Jose 40
Tianjin 40
Abidjan 39
Pescara 38
Boardman 37
Toronto 37
Salerno 36
Cambridge 35
Livorno 35
University Park 34
Amsterdam 33
Belo Horizonte 33
Hebei 33
Santa Clara 33
Brooklyn 32
Düsseldorf 32
Paris 32
Norwalk 31
Augusta 30
Jiaxing 30
Changsha 29
Modena 29
Shenyang 29
Stockholm 29
Hangzhou 28
Johannesburg 28
Totale 16.206
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.158
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.183
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 903
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 853
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 558
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 399
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 395
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 330
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 305
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 299
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 296
Pros-IT CNR: an Italian prostate cancer monitoring project 263
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 245
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 229
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 228
Le infezioni delle vie urinarie 222
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 215
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 205
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 201
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 181
Urological complications following inguinal hernioplasty 180
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 176
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 175
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 170
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 170
The occult urothelial cancer 170
Metabolic reprogramming by malat1 depletion in prostate cancer 170
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 167
Evidenze microbiologiche in un singolo centro urologico 167
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 166
Male infertility: non-surgical therapy 164
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 159
Human factors in surgery: from Three Mile Island to the operating room 155
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 155
Hot topics in urological health economics. A mini review 154
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 154
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 154
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 149
Extracorporeal shockwave lithotripsy in pediatrics 148
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 148
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 148
Imaging in prostate cancer diagnosis: present role and future perspectives 147
[Overactive bladder syndrome: the social and economic perspective] 147
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 147
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 146
Bladder and prostate metastasis from small cell lung cancer: a rare entity 146
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 146
Antibiotic prophylaxis in urology 145
Le complicanze nella chirurgia urologica 145
Chirurgia robotica per tutti 145
[Foreign bodies in urinary bladder: a clinical case] 144
Brachytherapy in men with prostate cancer: update on indications and outcomes 144
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 143
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 142
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 142
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 142
Microbiological follow-up of nosocomial infections in a single urological center 142
Advanced bladder cancer: New agents and new approaches. A review 141
Imaging in prostate cancer staging: present role e future perspectives 140
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 139
Imaging of renal cell carcinoma: state of the art and recent advances 138
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 137
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 136
Advanced bladder cancer: New agents and new approaches. A review 135
Size of Bladder Cancers: Correlation among Different Types of Measurement 135
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 135
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 133
Therapeutic strategies in penile cancer: state of the art 133
NBI: results review 133
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 132
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 131
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 129
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 129
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 128
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 127
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 126
Inhibition of prostate efferent neurotransmission by amikacin 126
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 126
Imaging in prostate cancer staging: present role and future perspectives 126
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 125
Stone composition and vascular calcifications in patients with nephrolithiasis 125
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 123
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 122
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 122
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 122
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 122
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 122
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 122
Circumcision: history, religion and law 121
[Innovative treatments of non muscle invasive bladder cancer] 121
Calcium oxalate nephrolithiasis: urinary "medium size peptides"analysis using MALDI-TOF mass spectrometry. 121
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 121
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 120
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 120
Local relapse of prostate cancer after primary definitive treatment: the management 119
Mitomycin C: new strategies to improve efficacy of a well-known therapy 118
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response 117
The occult urothelial cancer 117
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 116
Totale 29.863
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.146 0 0 0 0 0 135 196 76 221 108 305 105
2021/20222.276 218 147 77 182 186 112 79 297 138 161 304 375
2022/20235.995 686 637 419 779 341 641 270 479 639 280 480 344
2023/20246.891 384 811 433 550 478 598 528 628 449 613 641 778
2024/20259.615 640 753 881 716 953 638 643 723 1.104 746 994 824
2025/20266.032 1.722 482 702 1.115 1.886 125 0 0 0 0 0 0
Totale 39.478